Publication | Open Access

Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study

VaccinologyVaccine SafetyVaccinationPhase 1BPlacebo-controlled Dose-escalation StudyVaccine DevelopmentImmunologyMedicineVaccine Research